Highlights

  • Transition from illness to wellness has been a gamechanger
  • Pharma now seeing a huge partnership ecosystem
  • Booster is still a prime dose, not specific to a strain

Latest news

An important message from the heart for all you 'social' drinkers out there!

An important message from the heart for all you 'social' drinkers out there!

Omicron variant | Intensive containment, active surveillance, increased vaccination: Centre to states

Omicron variant | Intensive containment, active surveillance, increased vaccination: Centre to states

Oppo Reno7, Reno7 Pro, Reno7 SE launched in China: check specs and price

Oppo Reno7, Reno7 Pro, Reno7 SE launched in China: check specs and price

'I am done! Goodbye! INJUSTICE': comedian Munawar Faruqui hints at quitting comedy

'I am done! Goodbye! INJUSTICE': comedian Munawar Faruqui hints at quitting comedy

Heartbreak for Thailand as ICC cancels Women's World Cup Qualifier

Heartbreak for Thailand as ICC cancels Women's World Cup Qualifier

On Biz Buzz| Cipla Global CEO Exclusive, Covid & Beyond

Global collaboration now in pharma is a paradigm shift for innovation: Cipla 

As the pharma industry makes the transition for the world to move from ‘illness to wellness’ Umang Vohra, Global CEO & MD of Cipla says innovation not generics will be the next big bet for the sector.

In an exclusive chat with Editorji and Fortune India Cipla's Global CEO & MD says he expects to see over 70% of Indians vaccinated by June 2022 and is confident that Covid will become just another flu the world will learn to live with.

On the question of boosters, the Cipla chief says the current dose of boosters are not ’true boosters’ and are largely just an extra shot as the virus continues to mutate.


Up Next

On Biz Buzz| Cipla Global CEO Exclusive, Covid & Beyond

On Biz Buzz| Cipla Global CEO Exclusive, Covid & Beyond

CEA Krishnamurthy Subramanian Exclusive: India's recovery risk from energy crisis

CEA Krishnamurthy Subramanian Exclusive: India's recovery risk from energy crisis

On Biz Buzz| Ratings, Recovery and Risk, India’s CEA lays out the economic realty and priorities

On Biz Buzz| Ratings, Recovery and Risk, India’s CEA lays out the economic realty and priorities

On Biz Buzz | Cipla CEO Exclusive, game changing moves in approvals and discovery

On Biz Buzz | Cipla CEO Exclusive, game changing moves in approvals and discovery

On Biz Buzz| Raamdeo Agrawal gives you the investment mantra for Financial Freedom in this bull market

On Biz Buzz| Raamdeo Agrawal gives you the investment mantra for Financial Freedom in this bull market

On Biz Buzz | Want to invest in Crypto? WazirX founder tells you how

On Biz Buzz | Want to invest in Crypto? WazirX founder tells you how

More videos

On Biz Buzz | WazirX concedes crypto not as efficient as UPI, unlikely to be accepted as Payment mode
On Biz Buzz | Crypto unregulated not illegal says WazirX
On Biz Buzz| WazirX exclusive on revolution and risks of crypto to the need for regulation
On Biz Buzz | Intel gears up to ease India's traffic woes with AI
On Biz Buzz | Intel Exclusive, how UPI, Digital India is shrinking the digital gap
On Biz Buzz | Intel on the global chip shortage & India's need to digitally 'Atmanirbhar'
On Biz Buzz| Intel Exclusive on Global Chip shortage and Digital India's role in the tech revolution
On Biz Buzz | Ronnie Screwvala Exclusive on upGrad and edtech listing plans
On Biz Buzz | Ronnie Screwvala tells you the one skill you must have!
On Biz Buzz | Ronnie Screwvala explains how non-linear thinking is the only way ahead